Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunctionKei Kunimasa, Toru Kumagai, Toru Oka et al.|Lung Cancer|2020Cited by 43
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 TrialsToshiyuki Harada, Masaharu Nishimura, Takahiro Ogi et al.|Frontiers in Pharmacology|2018Cited by 19